What is Izotropic Corporation (IZOZF)?

Izotropic Corporation (IZOZF) is a stock in the Healthcare sector, Medical - Diagnostics & Research industry. View full analysis on Stocks360.

What is the current price of IZOZF?

The current price of IZOZF is $0.10. Prices are updated in real time on Stocks360.

What is IZOZF's price-to-earnings (PE) ratio?

IZOZF's trailing twelve-month PE ratio is -4.13, based on current price and earnings per share data available on Stocks360.

What is IZOZF's market capitalization?

IZOZF's market capitalization is $7,251,366.00, placing it in the small-cap tier.

Izotropic Corporation (IZOZF)

Stock analysis · OTC · Healthcare · Medical - Diagnostics & Research

$0.10

Market Cap

$7.25M

PE (TTM)

-4.13

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

2.42

Day Range

$0.10 – $0.10

52-wk Range

$0.10 – $0.34

Avg Volume

N/A

Volume

28.50K

Izotropic Corporation (IZOZF) is a publicly traded company in the Healthcare sector. Latest price: $0.10. Market cap $7.25M. Trailing PE -4.13. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

You have viewed 7 SEO analysis pages

Unlock saved watchlists, personalized setups, and referral credits with a free Stocks360 account.

Continue with free signup

1-Year Price

2025-10-31 · $0.33 2026-10-30 · $0.10 (-68.37%)

Earnings

Most Recent

Sep 28, 2026

EPS $-0.01 vs est. $0.01

Missed by $0.02

Proprietary Signals

Signal snapshot temporarily unavailable.

About Izotropic Corporation

Izotropic Corporation is a medical technology company focused on bringing advanced diagnostic solutions for breast cancer to market. The firm develops and sells both a specialized breast CT imaging system and a 3D CT breast imaging platform, which are designed to facilitate earlier detection and more accurate diagnosis of breast cancer. Founded in 2016, the company's operations are headquartered in Surrey, Canada.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-4.13×
P/S (TTM)	0.00×
P/B	-1.59×
P/FCF (TTM)	-13.82×
EV / EBITDA	-7.94×
EV / Sales	0.00×
Earnings Yield	-23.43%
Free Cash Flow Yield	-7.23%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$13.28M
Net Income (TTM)	-$2.37M
Free Cash Flow (TTM)	-$250.78K
Net Debt	$3.15M
Working Capital	-$6.24M
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Return on Equity	40.45%
Return on Invested Capital	50.46%